GlassScriptPhysician profile
Tri Luong
NPI 1013228782
$4,213.55
in general payments reported to CMS, 2019-2025
9 companies · $648 in 2025
The $648 reported for 2025 was more than what 94% of Hospice and Palliative Medicine (Family Medicine) providers received nationally (typical 2025 total: $78.57).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $795 · 2020: $833 · 2021: $955 · 2022: $404 · 2023: $259 · 2024: $319 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $2,554.97 | 2019-2025 | Cabenuva, Dovato, Apretude |
| Gilead Sciences, INC. | $589.51 | 2019-2025 | Biktarvy |
| Janssen Biotech, INC. | $426.05 | 2019-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $341.32 | 2019-2025 | Pifeltro, Delstrigo |
| Janssen Products, LP | $203.75 | 2019-2021 | |
| Theratechnologies INC. | $34.02 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Napo Pharmaceuticals INC | $18.67 | 2019 | |
| Emd Serono, INC. | $16.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tri Luong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.